Amedisys (AMED) PT Raised to 'Street High' $200 at Raymond James
Tweet Send to a Friend
Raymond James analyst John Ransom raised the price target on Amedisys (NASDAQ: AMED) to a 'Street High' $200.00 (from $144.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
